Women's Health Market Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2028

Jan 2018| TMR065A| Transparency

Report Highlights

Global Women's Health Market: Overview

This report on the women’s health market analyzes the current and future scenario of the global market. Rise in number of women facing menopausal condition, rising incidence of women’s diseases, growing awareness among people about the availability of treatment for women’s health related diseases, technological advancements and high R&D investments are major factors driving market growth.

The women’s health market report comprises an elaborate executive summary, which includes a market snapshot that provides information about various segments of the market. It also provides information and data analysis of the global market with respect to the segments based on treatment type, disease indication, and geography. A detailed qualitative analysis of drivers and restraints of the market and opportunities has been provided in the market overview section. In addition, the section comprises competitive matrix and company profiles with business overview to understand the competitive landscape in the market. This section of the report also provides market attractiveness analysis, by geography and market share analysis by key players, thus presenting a thorough analysis of the overall competitive scenario in the women’s health market.

Global Women's Health Market: Segmentation

Based on treatment type, the market has been segmented into hormonal treatment and non-hormonal treatment. Hormonal treatment segment is subdivided into estrogen therapy, progestin therapy, combination therapy, thyroid replacement therapy, parathyroid hormone therapy, and others. While non-hormonal treatment segment considers cancer targeted therapy drugs, antibiotics, bisphosphonates, and others (vitamin D treatment, calcitonin, RANK-Ligand, non-steroidal anti-inflammatory drugs etc.). The treatment type market segments have been analyzed based on available approved drugs, cost-effectiveness, and prevalence rate by geography. The market size in terms of value (US$) and forecast for each of these segments have been provided for the period from 2015 to 2025, along with their respective CAGRs for the forecast period from 2017 to 2025, considering 2016 as the base year.

Based on disease indication, the women’s health market has been segmented into following categories: cancer, hypothyroidism, post-menopausal syndrome, osteoporosis, contraceptive, uterine fibroid, urinary tract infection, and other disease indications. The market segments have been extensively analyzed based on new product launches, incidence and prevalence rate, and prescription pattern. The market size and forecast in terms of US$ Mn for each segment have been provided for the period from 2015 to 2025. The report also provides the compound annual growth rate (CAGR %) for each market segment for the forecast period from 2017 to 2025, considering 2016 as the base year.

Global Women’s Health Market: Regional Outlook

Geographically, the global women’s health market has been categorized into five major regions and the key countries in the respective region: North America (the U.S., Canada), Europe (the U.K., Germany, France, Spain, Italy, and Rest of Europe), Asia Pacific (India, China, Japan, Australia & New Zealand and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America) and Middle East & Africa (South Africa, GCC countries and Rest of Middle East & Africa). The market size and forecast for each of these regions and the mentioned countries have been provided for the period from 2015 to 2025, along with their respective CAGRs for the forecast period from 2017 to 2025, considering 2016 as the base year. The research study also covers the competitive scenario in these regions.

Competitive Landscape

The report also profiles major players in the global women’s health market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments. The major players in the women’s health market are – Eli Lilly and Company, Novartis AG, Pfizer, Inc., Merck & Co., Inc., Novo Nordisk A/S, Amgen Inc., Lupin Pharmaceuticals, Inc., AstraZeneca, F. Hoffmann-La Roche Ltd., Sanofi, Allergan Plc, Bayer AG, GlaxoSmithKline plc, and Johnson & Johnson and others.

The global women’s health market is segmented as given below:

Global Women’s Health Market, by Treatment Type

Hormonal Treatment
Estrogen Therapy
Progestin Therapy
Combination Therapy
Thyroid Replacement Therapy
Parathyroid Hormone Therapy
Others
Non-Hormonal Treatment
Targeted Therapy Drugs
Antibiotics
Bisphosphonates
Others
Global Women’s Health Market, by Disease Indication

Cancer
Breast Cancer
Cervical Cancer
Ovarian Cancer
Hypothyroidism
Post-Menopausal Syndrome
Osteoporosis
Contraceptive
Uterine Fibroid
Urinary Tract Infection
Others
Global Women’s Health Market, by Geography

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Spain
Rest of Europe
Asia Pacific
China
Japan
India
Australia and New Zealand
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East & Africa
South Africa
GCC Countries
Rest of MEA

  • Table 1 : Global Women’s Health Market Size (US$ Mn) Forecast, by Treatment Type, 2015–2025
  • Table 2 : Global Women’s Health Market Size (US$ Mn) Forecast, by Treatment Type – Hormonal Treatment, 2015–2025
  • Table 3 : Global Women’s Health Market Revenue (US$ Mn) and Y-o-Y (%) Forecast, by Hormonal Treatment
  • Table 4 : Global Women’s Health Market Revenue (US$ Mn) and Y-o-Y (%) Forecast, by Estrogen Treatment
  • Table 5 : Global Women’s Health Market Revenue (US$ Mn) and Y-o-Y (%) Forecast, by Progestin Treatment
  • Table 6 : Global Women’s Health Market Revenue (US$ Mn) and Y-o-Y (%) Forecast, by Combination Treatment
  • Table 7 : Global Women’s Health Market Revenue (US$ Mn) and Y-o-Y (%) Forecast, by Thyroid Treatment
  • Table 8 : Global Women’s Health Market Revenue (US$ Mn) and Y-o-Y (%) Forecast, by Parathyroid Treatment
  • Table 9 : Global Women’s Health Market Revenue (US$ Mn) and Y-o-Y (%) Forecast, by Others Treatment
  • Table 10 : Global Women’s Health Market Revenue (US$ Mn) and Y-o-Y (%) Forecast, by Non-Hormonal Treatment
  • Table 11 : Global Women’s Health Market Revenue (US$ Mn) and Y-o-Y (%) Forecast, by Targeted Therapy Drugs Treatment
  • Table 12 : Global Women’s Health Market Revenue (US$ Mn) and Y-o-Y (%) Forecast, by Antibiotics Therapy Drugs
  • Table 13 : Global Women’s Health Market Revenue (US$ Mn) and Y-o-Y (%) Forecast, by Bisphosphonate Therapy Drugs
  • Table 14 : Global Women’s Health Market Size (US$ Mn) Forecast, by Treatment Type – Non-Hormonal Treatment, 2015–2025
  • Table 15 : Global Women’s Health Market Size (US$ Mn) Forecast, by Disease Indication, 2015–2025
  • Table 16 : Global Women’s Health Market Size (US$ Mn) Forecast, by Region, 2015–2025
  • Table 17 : North America Women’s Health Market Size (US$ Mn) Forecast, by Country, 2015–2025
  • Table 18 : North America Women’s Health Market Size (US$ Mn) Forecast, by Treatment Type, 2015–2025
  • Table 19 : North America Women’s Health Market Size (US$ Mn) Forecast, by Hormonal Treatment, 2015–2025
  • Table 20 : North America Women’s Health Market Size (US$ Mn) Forecast, by Non-hormonal Treatment, 2015–2025
  • Table 21 : North America Women’s Health Market Size (US$ Mn) Forecast, by Disease Indication, 2015–2025
  • Table 22 : Europe Women’s Health Market Size (US$ Mn) Forecast, by Country, 2015–2025
  • Table 23 : Europe Women’s Health Market Size (US$ Mn) Forecast, by Treatment Type, 2015–2025
  • Table 24 : Europe Women’s Health Market Size (US$ Mn) Forecast, by Treatment Type – Hormonal Treatment, 2015–2025
  • Table 25 : Europe Women’s Health Market Size (US$ Mn) Forecast, by Treatment Type – Non-Hormonal Treatment, 2015–2025
  • Table 26 : Europe Women’s Health Market Size (US$ Mn) Forecast, by Disease Indication, 2015–2025
  • Table 27 : Asia Pacific Women’s Health Market Size (US$ Mn) Forecast, by Country, 2015–2025
  • Table 28 : Asia Pacific Women’s Health Market Size (US$ Mn) Forecast, by Treatment Type, 2015–2025
  • Table 29 : Asia Pacific Women’s Health Market Size (US$ Mn) Forecast, by Hormonal Treatment, 2015–2025
  • Table 30 : Asia Pacific Women’s Health Market Size (US$ Mn) Forecast, by Non-hormonal Treatment, 2015–2025
  • Table 31 : Asia Pacific Women’s Health Market Size (US$ Mn) Forecast, by Disease Indication, 2015–2025
  • Table 32 : Latin America Women’s Health Market Size (US$ Mn) Forecast, by Country, 2015–2025
  • Table 33 : Latin America Women’s Health Market Size (US$ Mn) Forecast, by Treatment Type, 2015–2025
  • Table 34 : Latin America Women’s Health Market Size (US$ Mn) Forecast, by Treatment Type – Hormonal Treatment, 2015–2025
  • Table 35 : Latin America Women’s Health Market Size (US$ Mn) Forecast, by Treatment Type – Non-Hormonal Treatment, 2015–2025
  • Table 36 : Latin America Women’s Health Market Size (US$ Mn) Forecast, by Disease Indication, 2015–2025
  • Table 37 : Middle East & Africa Women’s Health Market Size (US$ Mn) Forecast, by Country, 2015–2025
  • Table 38 : Middle East & Africa Women’s Health Market Size (US$ Mn) Forecast, by Treatment Type, 2015–2025
  • Table 39 : Middle East & Africa Women’s Health Market Size (US$ Mn) Forecast, by Hormonal Treatment, 2015–2025
  • Table 40 : Middle East & Africa Women’s Health Market Size (US$ Mn) Forecast, by Non-hormonal Treatment, 2015–2025
  • Table 41 : Middle East & Africa Women’s Health Market Size (US$ Mn) Forecast, by Disease Indication, 2015–2025
  • Figure 1 : Global Women’s Health Market Snapshot
  • Figure 2 : Revenue Share (2016)
  • Figure 3 : Key Industry Developments
  • Figure 4 : Porter’s Analysis
  • Figure 5 : Value Chain Analysis
  • Figure 6 : Market Value Share, by Treatment Type (2016)
  • Figure 7 : Market Value Share, by Disease Indication (2016)
  • Figure 8 : Market Value Share, by Region (2016)
  • Figure 9 : Global Women’s Health Market, by Treatment Type
  • Figure 10 : Global Women’s Health Market Value Share Analysis, by Treatment Type, 2016 and 2025
  • Figure 11 : Global Women’s Health Market Revenue (US$ Mn) and Y-o-Y (%) Forecast, by Hormonal Treatment
  • Figure 12 : Global Women’s Health Market Revenue (US$ Mn) and Y-o-Y (%) Forecast, by Estrogen Treatment
  • Figure 13 : Global Women’s Health Market Revenue (US$ Mn) and Y-o-Y (%) Forecast, by Progestin Treatment
  • Figure 14 : Global Women’s Health Market Revenue (US$ Mn) and Y-o-Y (%) Forecast, by Combination Treatment
  • Figure 15 : Global Women’s Health Market Revenue (US$ Mn) and Y-o-Y (%) Forecast, by Thyroid Treatment
  • Figure 16 : Global Women’s Health Market Revenue (US$ Mn) and Y-o-Y (%) Forecast, by Parathyroid Treatment
  • Figure 17 : Global Women’s Health Market Revenue (US$ Mn) and Y-o-Y (%) Forecast, by Others Treatment
  • Figure 18 : Global Women’s Health Market Revenue (US$ Mn) and Y-o-Y (%) Forecast, by Non-Hormonal Treatment
  • Figure 19 : Global Women’s Health Market Revenue (US$ Mn) and Y-o-Y (%) Forecast, by Targeted Therapy Drugs Treatment
  • Figure 20 : Global Women’s Health Market Revenue (US$ Mn) and Y-o-Y (%) Forecast, by Antibiotics Therapy Drugs
  • Figure 21 : Global Women’s Health Market Revenue (US$ Mn) and Y-o-Y (%) Forecast, by Bisphosphonate Therapy Drugs
  • Figure 22 : Global Women’s Health Market Value Share Analysis, by Disease Indication, 2016 and 2025
  • Figure 23 : Global Women’s Health Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Cancer
  • Figure 24 : Global Women’s Health Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Hypothyroidism
  • Figure 25 : Global Women’s Health Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Post-Menopausal Syndrome
  • Figure 26 : Global Women’s Health Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Osteoporosis
  • Figure 27 : Global Women’s Health Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Contraceptive
  • Figure 28 : Global Women’s Health Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Uterine Fibroid (UF)
  • Figure 29 : Global Women’s Health Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Urinary Tract Infection (UTI)
  • Figure 30 : Global Women’s Health Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others
  • Figure 31 : Global Market Scenario
  • Figure 32 : Global Women’s Health Market Value Share Analysis, by Region, 2016 and 2025
  • Figure 33 : Global Women’s Health Market Attractiveness Analysis, by Region
  • Figure 34 : North America Women’s Health Market Size (US$ Mn) and Y-o-Y (%) Forecast, 2015–2025
  • Figure 35 : North America Women’s Health Market Attractiveness Analysis, by Country, 2017-2025
  • Figure 36 : North America Women’s Health Market Value Share Analysis, by Country, 2016 and 2025
  • Figure 37 : North America Women’s Health Market Value Share Analysis, by Treatment Type, 2016 and 2025
  • Figure 38 : North America Women’s Health Market Value Share Analysis, by Disease Indication, 2016 and 2025
  • Figure 39 : North America Women’s Health Market Attractiveness Analysis, by Treatment Type, 2017-2025
  • Figure 40 : North America Women’s Health Market Attractiveness Analysis, by Disease Indication, 2017-2025
  • Figure 41 : Europe Women’s Health Market Size (US$ Mn) and Y-o-Y (%) Forecast, 2015–2025
  • Figure 42 : Europe Women’s Health Market Attractiveness Analysis, by Country, 2017-2025
  • Figure 43 : Europe Women’s Health Market Value Share Analysis, by Country, 2016 and 2025
  • Figure 44 : Europe Women’s Health Market Value Share Analysis, by Treatment Type, 2016 and 2025
  • Figure 45 : Europe Women’s Health Market Value Share Analysis, by Disease Indication, 2016 and 2025
  • Figure 46 : Europe Women’s Health Market Attractiveness Analysis, by Treatment Type, 2017-2025
  • Figure 47 : Europe Women’s Health Market Attractiveness Analysis, by Disease Indication, 2017-2025
  • Figure 48 : Asia Pacific Women’s Health Market Size (US$ Mn) and Y-o-Y (%) Forecast, 2015–2025
  • Figure 49 : Asia Pacific Women’s Health Market Attractiveness Analysis, by Country, 2017-2025
  • Figure 50 : Asia Pacific Women’s Health Market Value Share Analysis, by Country, 2016 and 2025
  • Figure 51 : Asia Pacific Women’s Health Market Value Share Analysis, by Treatment Type, 2016 and 2025
  • Figure 52 : Asia Pacific Women’s Health Market Value Share Analysis, by Disease Indication, 2016 and 2025
  • Figure 53 : Asia Pacific Women’s Health Market Attractiveness Analysis, by Treatment Type, 2017-2025
  • Figure 54 : Asia Pacific Women’s Health Market Attractiveness Analysis, by Disease Indication, 2017-2025
  • Figure 55 : Latin America Women’s Health Market Size (US$ Mn) and Y-o-Y (%) Forecast, 2015–2025
  • Figure 56 : Latin America Women’s Health Market Attractiveness Analysis, by Country, 2017-2025
  • Figure 57 : Latin America Women’s Health Market Value Share Analysis, by Country, 2016 and 2025
  • Figure 58 : Latin America Women’s Health Market Value Share Analysis, by Treatment Type, 2016 and 2025
  • Figure 59 : Latin America Women’s Health Market Value Share Analysis, by Disease Indication, 2016 and 2025
  • Figure 60 : Latin America Women’s Health Market Attractiveness Analysis, by Treatment Type, 2017-2025
  • Figure 61 : Latin America Women’s Health Market Attractiveness Analysis, by Disease Indication, 2017-2025
  • Figure 62 : Middle East & Africa Women’s Health Market Size (US$ Mn) and Y-o-Y (%) Forecast, 2015–2025
  • Figure 63 : Middle East & Africa Women’s Health Market Attractiveness Analysis, by Country, 2017-2025
  • Figure 64 : Middle East & Africa Women’s Health Market Value Share Analysis, by Country, 2016 and 2025
  • Figure 65 : Middle East & Africa Women’s Health Market Value Share Analysis, by Treatment Type, 2016 and 2025
  • Figure 66 : Middle East & Africa Women’s Health Market Value Share Analysis, by Disease Indication, 2016 and 2025
  • Figure 67 : Middle East & Africa Women’s Health Market Attractiveness Analysis, by Treatment Type, 2017-2025
  • Figure 68 : Middle East & Africa Women’s Health Market Attractiveness Analysis, by Disease Indication, 2017-2025
  • Figure 69 : Competitive Positioning, 2016
  • Figure 70 : Breakdown of Net Sales, by Region, 2016
  • Figure 71 : Revenue (US$ Mn) and Y-o-Y Growth (%), 2013–2016

Leaders in analytics, research and advisory services for Fortune 500 companies, scores of high potential startups, and financial institutions. Our success stories have proven why we are a prominent provider of a cutting-edge syndicated and customized research services. Leverage the best of our seasoned research analysts who had a keen interest and enviable expertise of almost 4 million hours in global, regional, and local market intelligence.

Why BCC Research?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
CUSTOM RESEARCH

Need a custom data table, graph or complete report? Tell us more.

Contact Us
Share This Report